Transparency Market Research in its new report titled, “Mesenchymal Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026,” provides key insights on the mesenchymal stem cells market. The new report anticipates that the increasing clinical applications of mesenchymal stem cells for the treatment of chronic diseases, bone and cartilage diseases, and autoimmune diseases will drive the mesenchymal stem cells market during the forecast period i.e, 2018-2026. The report says that the studies have shown that these stem cells enhance the angiogenesis in myocardium and allow the reduction of myocardial fibrotic area. The pre-clinical studies for using mesenchymal stem cells in treatment of cardiovascular diseases, liver diseases, and cancer are projected to create new market opportunities for mesenchymal stem cells.
The report has segregated the global mesenchymal stem cells market on the basis of source of isolation, end-user, and region. Stem cells are isolated from the bone marrow, peripheral blood, lung tissue, umbilical cord blood, amniotic fluids, adipose tissues, and synovial tissues. Traditionally the MSC’s were isolated from bone marrow aspiration which is associated with risk of infection and painful for the patient. The MSC’s from adipose tissues are usually isolated from the biological material generated during liposuction, lipectomy procedures by using collagenase enzymatic digestion followed by centrifugation and washing. In terms of end-user, the market is segmented into clinical research organizations, biotechnological companies, medical research institutes, and hospitals.
In accordance with the regional perspective, the TMR report has segregated the global mesenchymal stent cells market into over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Out of these, North America has dominated the global market in the past and is projected to continue its dominance in terms of market share during the forecast period owing to high R&D expenditure, availability of advanced research facilities and skilled professionals, and government initiatives. Europe is the second largest market after North America for the global mesenchymal stem cells. The Asia Pacific market is projected to expand at a high CAGR during the forecast period due to increased R&D budgets in Japan, China, and India.
Major global players operating in the mesenchymal stem cells market are included in this report to give a better competitive analysis and these include R&D Systems, Inc., Cell Applications, Inc., Axol Bioscience Ltd., Cyagen Biosciences Inc., Cytori Therapeutics Inc., Stemcelltechnologies Inc., BrainStorm Cell Therapeutics, Stemedica Cell Technologies, Inc., and Celprogen, Inc.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]